Robert J Alpern Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert J Alpern.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert J Alpern. Robert J Alpern is in ABBOTT LABORATORIES ($ABT) and Director in ABBOTT LABORATORIES ($ABT) and Director in AbbVie Inc. ($ABBV) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA).
Latest Insider Trading Transactions of Robert J Alpern
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABT, ABBV, TCDA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 11 2021 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Grant | A | 115.96 | 1,681 | 194,929 | 30,121 | 28.4 K to 30.1 K (+5.91 %) |
Apr 27 2021 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Grant | A | 0.00 | 1,499 | 0 | 33,879 | 32.4 K to 33.9 K (+4.63 %) | |
Apr 02 2021 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Option Exercise | A | 0.00 | 65 | 0 | 8,308 | ||
Apr 01 2021 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 108.22 | 66 | 7,143 | 7,764 | |
Oct 02 2020 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 82 | 0 | 7,489 | |
Oct 02 2020 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 82 | 0 | 7,489 | |
Jul 02 2020 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 71 | 0 | 7,353 | |
Jul 01 2020 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 86 | 0 | 8,015 | |
Jun 15 2020 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Option Exercise | A | 25.40 | 22,967 | 583,362 | 22,967 | |
Jun 15 2020 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Grant | A | 0.00 | 5,670 | 0 | 143,060 | 137.4 K to 143.1 K (+4.13 %) |
May 12 2020 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Grant | A | 0.00 | 2,333 | 0 | 28,440 | 26.1 K to 28.4 K (+8.94 %) |
Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Grant | A | 0.00 | 1,974 | 0 | 32,380 | 30.4 K to 32.4 K (+6.49 %) |
Apr 02 2020 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 99 | 0 | 7,897 | |
Apr 02 2020 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 90 | 0 | 7,110 | |
Jan 03 2020 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 90 | 0 | 7,766 | |
Jan 03 2020 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 77 | 0 | 6,933 | |
Nov 27 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 39.59 | 1,000 | 39,590 | 137,390 | 138.4 K to 137.4 K (-0.72 %) |
Nov 21 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 40.65 | 2,439 | 99,145 | 138,390 | 140.8 K to 138.4 K (-1.73 %) |
Nov 14 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 39.92 | 1,159 | 46,267 | 140,829 | 142 K to 140.8 K (-0.82 %) |
Nov 12 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 39.93 | 3,953 | 157,843 | 141,988 | 145.9 K to 142 K (-2.71 %) |
Nov 07 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 39.75 | 227 | 9,023 | 145,941 | 146.2 K to 145.9 K (-0.16 %) |
Nov 07 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 39.89 | 1,605 | 64,023 | 146,168 | 147.8 K to 146.2 K (-1.09 %) |
Nov 06 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 39.84 | 2,617 | 104,261 | 147,773 | 150.4 K to 147.8 K (-1.74 %) |
Oct 29 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 36.29 | 1,000 | 36,290 | 150,390 | 151.4 K to 150.4 K (-0.66 %) |
Oct 29 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 36.29 | 1,000 | 36,290 | 150,390 | 151.4 K to 150.4 K (-0.66 %) |
Oct 29 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 37.24 | 346 | 12,885 | 151,390 | 151.7 K to 151.4 K (-0.23 %) |
Oct 29 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 37.24 | 346 | 12,885 | 151,390 | 151.7 K to 151.4 K (-0.23 %) |
Oct 29 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 36.52 | 9,654 | 352,564 | 151,736 | 161.4 K to 151.7 K (-5.98 %) |
Oct 29 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 36.52 | 9,654 | 352,564 | 151,736 | 161.4 K to 151.7 K (-5.98 %) |
Oct 02 2019 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 94 | 0 | 7,647 | |
Oct 01 2019 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 90 | 0 | 6,773 | |
Sep 30 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 32.63 | 21 | 685 | 161,390 | 161.4 K to 161.4 K (-0.01 %) |
Sep 30 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 32.63 | 21 | 685 | 161,390 | 161.4 K to 161.4 K (-0.01 %) |
Sep 30 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 32.15 | 461 | 14,821 | 161,411 | 161.9 K to 161.4 K (-0.28 %) |
Sep 30 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 32.15 | 461 | 14,821 | 161,411 | 161.9 K to 161.4 K (-0.28 %) |
Sep 30 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 30.76 | 518 | 15,934 | 161,872 | 162.4 K to 161.9 K (-0.32 %) |
Sep 30 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 30.76 | 518 | 15,934 | 161,872 | 162.4 K to 161.9 K (-0.32 %) |
Aug 28 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 33.19 | 1,000 | 33,190 | 162,390 | 163.4 K to 162.4 K (-0.61 %) |
Jul 29 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 31.60 | 1,000 | 31,600 | 163,390 | 164.4 K to 163.4 K (-0.61 %) |
Jul 05 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 37.05 | 3,000 | 111,150 | 164,390 | 167.4 K to 164.4 K (-1.79 %) |
Jul 02 2019 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 94 | 0 | 6,571 | |
Jul 01 2019 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 93 | 0 | 7,524 | |
Jun 04 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Option Exercise | A | 36.74 | 7,068 | 259,678 | 7,068 | |
Jun 04 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Grant | A | 0.00 | 1,879 | 0 | 167,390 | 165.5 K to 167.4 K (+1.14 %) |
May 07 2019 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Grant | A | 0.00 | 2,419 | 0 | 26,107 | 23.7 K to 26.1 K (+10.21 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Grant | A | 0.00 | 2,241 | 0 | 30,406 | 28.2 K to 30.4 K (+7.96 %) |
Apr 02 2019 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 98 | 0 | 7,400 | |
Apr 02 2019 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 85 | 0 | 6,389 | |
Mar 29 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 33.63 | 14,000 | 470,820 | 165,511 | 179.5 K to 165.5 K (-7.80 %) |
Jan 03 2019 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 74 | 0 | 6,222 | |
Oct 02 2018 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 107 | 0 | 7,133 | |
Oct 02 2018 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 72 | 0 | 6,082 | |
Jul 03 2018 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 129 | 0 | 6,995 | |
Jul 02 2018 | TCDA | Tricida, Inc. | Alpern Robert J | Option Exercise | A | 19.00 | 13,147 | 249,793 | 13,147 | ||
Jul 02 2018 | TCDA | Tricida, Inc. | Alpern Robert J | Option Exercise | A | 19.00 | 13,147 | 249,793 | 13,147 | ||
Jul 02 2018 | TCDA | Tricida, Inc. | Alpern Robert J | Grant | A | 0.00 | 3,632 | 0 | 179,511 | 175.9 K to 179.5 K (+2.07 %) | |
Jul 02 2018 | TCDA | Tricida, Inc. | Alpern Robert J | Grant | A | 0.00 | 3,632 | 0 | 179,511 | 175.9 K to 179.5 K (+2.07 %) | |
Jul 02 2018 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 71 | 0 | 5,951 | |
Jul 02 2018 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 71 | 0 | 5,951 | |
May 07 2018 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Grant | A | 0.00 | 1,899 | 0 | 23,688 | 21.8 K to 23.7 K (+8.72 %) |
May 07 2018 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Grant | A | 0.00 | 1,899 | 0 | 23,688 | 21.8 K to 23.7 K (+8.72 %) |
May 01 2018 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Grant | A | 0.00 | 2,945 | 0 | 28,165 | 25.2 K to 28.2 K (+11.68 %) |
Apr 02 2018 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 131 | 0 | 6,834 | |
Apr 02 2018 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 69 | 0 | 5,825 | |
Jan 03 2018 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 67 | 0 | 5,721 | |
Oct 03 2017 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 147 | 0 | 6,502 | |
Jul 05 2017 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 162 | 0 | 6,320 | |
Jul 05 2017 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 90 | 0 | 5,491 | |
May 09 2017 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Grant | A | 0.00 | 2,770 | 0 | 21,789 | 19 K to 21.8 K (+14.56 %) |
May 02 2017 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Grant | A | 0.00 | 3,437 | 0 | 25,220 | 21.8 K to 25.2 K (+15.78 %) |
Apr 04 2017 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 100 | 0 | 5,349 | |
Apr 04 2017 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 177 | 0 | 6,121 | |
Jan 04 2017 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 205 | 0 | 5,908 | |
Jan 04 2017 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 104 | 0 | 5,194 | |
Oct 04 2016 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 186 | 0 | 5,666 | |
Oct 04 2016 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 104 | 0 | 5,044 | |
Jul 15 2016 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 120 | 0 | 4,898 | |
Jul 05 2016 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 200 | 0 | 5,449 | |
May 10 2016 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Grant | A | 0.00 | 2,974 | 0 | 19,019 | 16 K to 19 K (+18.54 %) |
May 03 2016 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Grant | A | 0.00 | 3,799 | 0 | 21,783 | 18 K to 21.8 K (+21.12 %) |
Apr 04 2016 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 137 | 0 | 4,735 | |
Apr 01 2016 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 188 | 0 | 5,213 | |
Jan 05 2016 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 175 | 0 | 4,990 | |
Jan 05 2016 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 132 | 0 | 4,549 | |
Oct 02 2015 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 195 | 0 | 4,789 | |
Oct 02 2015 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 144 | 0 | 4,378 | |
Jul 02 2015 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 117 | 0 | 4,202 | |
Jul 02 2015 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 160 | 0 | 4,571 | |
May 12 2015 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Grant | A | 0.00 | 2,187 | 0 | 16,045 | 13.9 K to 16 K (+15.78 %) |
Apr 28 2015 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Grant | A | 0.00 | 2,793 | 0 | 17,984 | 15.2 K to 18 K (+18.39 %) |
Apr 02 2015 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 134 | 0 | 4,054 | |
Apr 02 2015 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 169 | 0 | 4,389 |
Page: 1